Speaker illustration

Doctor Mauro Chiarito

Clinical Institute Humanitas IRCCS, Rozzano (Italy)

Member of:

Heart Failure Association

Prasugrel or clopidogrel in patients with acute coronary syndromes at high thrombotic risk: results from the PROMETHEUS study

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Highlights from the Young in coronary artery disease


Impact of dual antiplatelet non-adherence after percutaneous coronary intervention in patients with or without history of myocardial infarction

Event: ACVC 2021

Topic: Antiplatelet Drugs

Session: ePoster session


Predictors of haemodynamic performance in patients with aortic stenosis and small annulus undergoing TAVI with self-expandable valves

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Optimizing Risk Stratification and Technical Aspects of TAVI Procedures


Radial versus femoral access for coronary angiography and interventions: a systematic review and meta-analysis of randomized trials

Event: ESC Congress 2020

Topic: Coronary Angiography

Session: Interventional Cardiology ePosters


Clinical outcome of percutaneous coronary intervention (PCI) in elderly and very elderly patients: 1-year results from a tertiary-centre experience

Event: ESC Congress 2016

Topic: PCI: primary PCI / patient subsets

Session: Impact of stent design on post PCI outcomes


One year outcome after mitraclip procedure for functional and degenerative significant mitral regurgitation: a systematic review and meta-analysis.

Event: ESC Congress 2016

Topic: Mitral valve disease

Session: Secondary mitral regurgitation: a clinical challenge


ESC 365 is supported by

logo Novo Nordisk